YJA 20379-4

proton pump antagonist; structure in first source

Also Known As:

2-(3-(2,3-dihydro-1H-pyrrolo(1,2-a)benzimidazolyl)sulfinyl)-5-methyl-1H-benzimadazole; YJA20379-4

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ulcer 05/01/1998 - "In experimental ulcer models, YJA20379-4 administered by the oral route dose-dependently prevented the development of gastro-duodenal lesions in rats. "
2.	Stomach Ulcer (Gastric Ulcer) 05/01/1998 - "Moreover, repeated administration of YJA20379-4 promoted the healing of gastric ulcers induced by acetic acid. "
3.	Peptic Ulcer (Peptic Ulcers) 05/01/1998 - "Thus, YJA20379-4 might prove to be a beneficial therapy for gastritis and peptic ulcer diseases."
4.	Gastritis 05/01/1998 - "Thus, YJA20379-4 might prove to be a beneficial therapy for gastritis and peptic ulcer diseases."

1.	Acetic Acid (Vinegar)

1.	Therapeutics